Related Experiment Video
Updated: Jun 14, 2026

Real-time X-ray Imaging of Lung Fluid Volumes in Neonatal Mouse Lung
Published on: July 18, 2016
Ontogeny of hepatic and renal systemic clearance pathways in infants: part II
Jane Alcorn1, Patrick J McNamara
1Division of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington 40536, USA.
Insights
A new mathematical model estimates drug clearance in infants by analyzing liver enzyme and kidney function maturation. This Infant Scaling Factor (ISF) helps predict how well babies eliminate medications compared to adults.
Area of Science:
- Pharmacokinetics
- Pediatric Pharmacology
- Drug Metabolism
Background:
- Infant drug clearance mechanisms undergo significant postnatal maturation.
- Understanding these changes is crucial for safe and effective pediatric drug dosing.
Purpose of the Study:
- To develop a mathematical model for predicting drug clearance in infants up to 6 months old.
- To estimate an Infant Scaling Factor (ISF) reflecting the maturation of hepatic and renal clearance pathways.
Main Methods:
- Utilized age-specific in vitro hepatic microsomal activity and in vivo glomerular filtration data.
- Developed a model to predict an age- and pathway-specific Infant Scaling Factor (ISF).
- Validated the model by predicting infant systemic clearance for drugs eliminated by specific CYP enzymes or glomerular filtration.
Main Results:
- The model reasonably predicted clearance for CYP1A2 and CYP3A4, but less accurately for CYP2D6 and CYP2C.
- Renal clearance predictions were reasonable, suggesting adult values (normalized to bodyweight) may approximate infant values.
- The ISF directly correlates adult clearance with an infant's drug elimination capacity.
Conclusions:
- The developed model provides a valuable tool for estimating infant drug clearance.
- Further model refinement is needed for certain cytochrome P450 enzymes.
- Adult renal clearance values normalized to bodyweight may serve as reasonable predictors for infants.
Abstract:
Maturation of drug systemic clearance mechanisms during the postnatal period produces dramatic and rapid changes in an infant's capacity to eliminate drugs. A tentative general mathematical model describing the ontogeny of hepatic cytochrome P450 (CYP) enzyme-mediated clearance and renal clearance due to glomerular filtration in the first 6 months of life was elaborated from age-specific in vitro hepatic microsomal activity data (normalised to amount of hepatic microsomal protein) for enzyme-specific probe substrates and in vivo probe substrate data for glomerular filtration (normalised to bodyweight), respectively. The model predicts an age- and clearance pathway-specific Infant Scaling Factor (ISF) for the first 6 months of life. The ISF reflects functional maturation of a specific clearance pathway (normalised to bodyweight) relative to adult values. Therefore, the ISF directly correlates adult clearance values with an infant's capacity to eliminate drugs. Substitution of appropriate model parameter estimates and the age of the infant into the model provides an estimated ISF value, which may then be used to predict the contribution of a particular clearance pathway to total systemic clearance in the infant when adult systemic clearance values are known. The model was tested for its ability to predict infant systemic clearance of drugs whose elimination is principally mediated by a single CYP enzyme or by glomerular filtration. The model performed reasonably well for CYP1A2 and CYP3A4, but poorer predictions were obtained for CYP2D6 and CYP2C because of lack of model complexity and/or inadequate hepatic microsomal activity data to fully describe the maturational process of functional enzyme. For renal clearance due to glomerular filtration, data normalised to bodyweight (kg) showed a limited maturational trend, suggesting that adult renal clearances normalised to bodyweight might reasonably predict infant renal clearances in the first 6 months of life. The model provided reasonable predictions of renal clearance due to glomerular filtration in the infant.
Related Concept Videos
Renal Drug Clearance: Overview
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
Most drugs undergo restrictive clearance, which is proportional to the...
Hepatic Drug Clearance: Role of Transporters
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion

